Persistence with topical glaucoma therapy among newly diagnosed Japanese patients

Japanese Journal of Ophthalmology

Volumn 58, Issue 1, 2014, Pages 68-74

  Kashiwagi, Kenji ^a   Furuya, Toshie ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Beta blocker; Carbonic anhydrase inhibitor; Glaucoma; Persistence; Prostaglandin

Indexed keywords

ANTIGLAUCOMA AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; EYE DROPS; PROSTAGLANDIN DERIVATIVE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; GLAUCOMA; GLAUCOMA SURGERY; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; JAPAN HEALTH INSURANCE SOCIETY; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PRIORITY JOURNAL; VISION;

ADMINISTRATION, TOPICAL; ADRENERGIC BETA-ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; CARBONIC ANHYDRASE INHIBITORS; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PATIENT COMPLIANCE; PROSTAGLANDINS, SYNTHETIC;

EID: 84893700425     PISSN: 00215155     EISSN: 16132246     Source Type: Journal    
DOI: 10.1007/s10384-013-0284-2     Document Type: Article

References (21)

1. Quigley HA. Improving eye drop treatment for glaucoma through better adherence. Optom Vis Sci. 2008;85:374-5.
2. Okeke CO, Quigley HA, Jampel HD, Ying GS, Plyler RJ, Jiang Y, et al. Adherence with topical glaucoma medication monitored electronically. The travatan dosing aid study. Ophthalmology. 2009;116:191-9.
3. Friedman DS, Quigley HA, Gelb L, Tan J, Margolis J, Shah SN, et al. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the glaucoma adherence and persistency study (GAPS). Invest Ophthalmol Vis Sci. 2007;48:5052-7.
4. Lu VH, Goldberg I, Lu CY. Use of glaucoma medications: state of the science and directions for observational research. Am J Ophthalmol. 2010;150(569-74):e9.
5. Nordstrom BL, Friedman DS, Mozaffari E, Quigley HA, Walker AM. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol. 2005;140:598-606.
6. Quek DT, Ong GT, Perera SA, Lamoureux EL, Aung T. Persistence of patients receiving topical glaucoma monotherapy in an Asian population. Arch Ophthalmol. 2011;129:643-8.
7. Park MH, Kang KD, Moon J. Noncompliance with glaucoma medication in Korean patients: a multicenter qualitative study. Jpn J Ophthalmol. 2013;57:47-56.
8. Kimura S, Sato T, Ikeda S, Noda M, Nakayama T. Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage. J Epidemiol. 2010;20:413-9.
9. Reardon G, Schwartz GF, Mozaffari E. Patient persistency with topical ocular hypotensive therapy in a managed care population. Am J Ophthal. 2004;137:S3-12.
10. Reardon G, Kotak S, Schwartz GF. Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review. Patient Prefer Adherence. 2011;5:441-63.
11. Robin AL, Novack GD, Covert DW, Crockett RS, Marcic TS. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. Am J Ophthalmol. 2007;144:533-40.
12. Hahn SR, Friedman DS, Quigley HA, Kotak S, Kim E, Onofrey M, et al. Effect of patient-centered communication training on discussion and detection of nonadherence in glaucoma. Ophthalmology. 2010;117(1339-47):e6.
13. Friedman DS, Hahn SR, Quigley HA, Kotak S, Kim E, Onofrey M, et al. Doctor-patient communication in glaucoma care: analysis of videotaped encounters in community-based office practice. Ophthalmology. 2009;116(2277-85):e1-3.
14. Kosoko O, Quigley HA, Vitale S, Enger C, Kerrigan L, Tielsch JM. Risk factors for noncompliance with glaucoma follow-up visits in a residents' eye clinic. Ophthalmology. 1998;105:2105-11.
15. De Natale R, Le Pen C, Berdeaux G. Efficiency of glaucoma drug regulation in 5 European countries: a 1995-2006 longitudinal prescription analysis. J Glaucoma. 2011;20:234-9.
16. Dasgupta S, Oates V, Bookhart BK, Vaziri B, Schwartz GF, Mozaffari E. Population-based persistency rates for topical glaucoma medications measured with pharmacy claims data. Am J Manag Care. 2002;8:S255-61.
17. Kashiwagi K. Efficacy and safety of switching to travoprost/timolol fixed-combination therapy from latanoprost monotherapy. Jpn J Ophthalmol. 2012;56:339-45.
18. Patel SC, Spaeth GL. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg. 1995;26:233-6.
19. Sleath B, Robin AL, Covert D, Byrd JE, Tudor G, Svarstad B. Patient-reported behavior and problems in using glaucoma medications. Ophthalmology. 2006;113:431-6.
20. Juzych MS, Randhawa S, Shukairy A, Kaushal P, Gupta A, Shalauta N. Functional health literacy in patients with glaucoma in urban settings. Arch Ophthalmol. 2008;126:718-24.
21. Muir KW, Ventura A, Stinnett SS, Enfiedjian A, Allingham RR, Lee PP. The influence of health literacy level on an educational intervention to improve glaucoma medication adherence. Patient Educ Couns. 2012;87:160-4.